TrialAsian Pacific journal of cancer prevention : APJCP2022

Efficacy of Olanzapine 5 mg versus 10 mg for the Prophylaxis of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving High Emetic Risk Chemotherapy without Neurokinin-1 Receptor Antagonist.

Sitthi Sukauichai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.